Observational studyClinical cancer research : an official journal of the American Association for Cancer Research2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.
Atsuto Mouri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.